Rhythm Control Versus Rate Control for New Onset Atrial Fibrillation (NCT05950971) | Clinical Trial Compass
TerminatedNot Applicable
Rhythm Control Versus Rate Control for New Onset Atrial Fibrillation
Stopped: Study enrollment too slow, 1 over 6 months
South Korea1 participantsStarted 2021-07-01
Plain-language summary
Adult patients who are diagnosed new onset atrial fibrillation with rapid ventricular response within 7 days after non-cardiac non-thoracic surgery are enrolled.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Older than 18 years
* Newly diagnosed atrial fibrillation or flutter
* Patients with atrial fibrillation or flutter that occurred within 7 days after non-cardiac non-thoracic surgery
* Atrial fibrillation or flutter with rapid ventricular response(HR ≥110/min)
* Patients without hemodynamic instability (MBP≥65mmHg with norepinephrine continuous infusion less than 5mcg/min or without vasopressor support)
Exclusion Criteria:
* Atrial fibrillation or flutter prolonged more than 48 hours without anticoagulation
* Patients who have decreased cardiac function or heart failure (EF \<40%)
* Patients who have cardiac conduction disorder, QT prolongation(QTc ≥500ms)